As such, there have been recommendations to use creatinine in conjunction with other biomarkers, including cystatin C and urine neutrophil gelatinase–associated lipocalin (NGAL), along with clinical assessments of urine output, to more properly diagnose AKI [53]. This evidence concerns the gene LCN2 and acute kidney injury.